Mice treated with anti-PD-1 or DNase I exhibited improved survival (Figure 1B) and reduction of tumor size, as indicated by caliper measurements, compared to the isotype-treated group (Figure 1C,D). This evidence concerns the gene PDCD1 and neoplasm.